Popular Trials
Ribonucleotide Reductase Inhibitor
Triapine + Radiation Therapy for Neuroendocrine Cancer
Recruiting1 awardPhase 1
Phoenix, Arizona
This trial is testing the side effects and best dose of triapine when given with lutetium Lu 177 dotatate for neuroendocrine tumors. Triapine may stop tumor growth by blocking enzymes needed for cell growth. Lutetium Lu 177 dotatate is a radioactive drug that carries radiation directly to tumor cells. Giving triapine and lutetium Lu 177 dotatate together may be a good way to treat neuroendocrine tumors.
Popular Filters
Trials for Neuroendocrine Tumors Patients
Behavioural Intervention
Virtual Reality Therapy for Gastrointestinal Cancer Pain
Recruiting0 awards4 criteria
Los Angeles, California
This trial will assess the impact of immersive VR on pain and other patient-reported outcomes for people with digestive tract malignancies, as well as differences between skills-based VR therapy and distraction VR therapy.
Tyrosine Kinase Inhibitor
Cabozantinib for Pancreatic Neuroendocrine Tumors
Recruiting1 awardPhase 3
Anchorage, Alaska
This trial compares cabozantinib to placebo in treating neuroendocrine or carcinoid tumors. Cabozantinib is a chemotherapy drug that targets specific tyrosine kinase receptors, which when blocked, may slow tumor growth.
Radioisotope Therapy
Personalized PRRT for Neuroendocrine Tumors
Recruiting3 awardsPhase 2
Quebec City, Quebec
This trial is testing a new way to give a cancer treatment called peptide receptor radionuclide therapy (PRRT). In this new way, the amount of PRRT given to each person will be different and personalized, based on how their body is expected to absorb the therapy. The goal is to maximize the amount of PRRT that gets to the tumor, while minimizing the amount that gets to healthy organs.
Trials for DSNET Patients
Behavioural Intervention
Virtual Reality Therapy for Gastrointestinal Cancer Pain
Recruiting0 awards4 criteria
Los Angeles, California
This trial will assess the impact of immersive VR on pain and other patient-reported outcomes for people with digestive tract malignancies, as well as differences between skills-based VR therapy and distraction VR therapy.
Tyrosine Kinase Inhibitor
Cabozantinib for Pancreatic Neuroendocrine Tumors
Recruiting1 awardPhase 3
Anchorage, Alaska
This trial compares cabozantinib to placebo in treating neuroendocrine or carcinoid tumors. Cabozantinib is a chemotherapy drug that targets specific tyrosine kinase receptors, which when blocked, may slow tumor growth.
Radioisotope Therapy
Personalized PRRT for Neuroendocrine Tumors
Recruiting3 awardsPhase 2
Quebec City, Quebec
This trial is testing a new way to give a cancer treatment called peptide receptor radionuclide therapy (PRRT). In this new way, the amount of PRRT given to each person will be different and personalized, based on how their body is expected to absorb the therapy. The goal is to maximize the amount of PRRT that gets to the tumor, while minimizing the amount that gets to healthy organs.
Trials With No Placebo
Somatostatin Analog
Paltusotine for Carcinoid Syndrome
Recruiting1 awardPhase 2
Lexington, Kentucky
This trial is testing a new medication called paltusotine to see if it is safe and how it behaves in people with carcinoid syndrome. Researchers want to understand how the drug moves through the body and its effects at different doses. The study includes a part where patients receive different treatments and a part where all patients receive paltusotine.
Radioisotope Therapy
Personalized PRRT for Neuroendocrine Tumors
Recruiting3 awardsPhase 2
Quebec City, Quebec
This trial is testing a new way to give a cancer treatment called peptide receptor radionuclide therapy (PRRT). In this new way, the amount of PRRT given to each person will be different and personalized, based on how their body is expected to absorb the therapy. The goal is to maximize the amount of PRRT that gets to the tumor, while minimizing the amount that gets to healthy organs.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.